CT imaging features associated with recurrence in non-small cell lung cancer patients after stereotactic body radiotherapy

Abstract

Our analysis reveals disease progression could be prognosticated as early as 3 months after SBRT using CT imaging features, and these features would be helpful in clinical decision-making.